Troy E. Wilson

Insider Reports History

Location
C/O Kura Oncology, Inc., 12730 High Bluff Drive, Suite 400, San Diego, CA
Signature
Teresa Bair, Attorney-in-fact for Troy E. Wilson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Troy E. Wilson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avidity Biosciences, Inc. Director Common Stock 54.4K $2.72M $50.00 Sep 5, 2025 Direct
Kura Oncology, Inc. President and CEO, Director Common Stock 429K $2.21M $8.94 Nov 13, 2025 Direct
Kura Oncology, Inc. President and CEO, Director Common Stock 300K $1.81M $6.02 Nov 13, 2025 by Lorax Charitable Remainder Unitrust
Kura Oncology, Inc. President and CEO, Director Common Stock 279K $1.68M $6.02 Nov 13, 2025 by One Fish Two Fish Revocable Trust
Avidity Biosciences, Inc. Director Common Stock 13.7K $652K $47.52 Sep 5, 2025 By family trust
PUMA BIOTECHNOLOGY, INC. Director Common Stock 43.6K $148K $3.40 Jun 13, 2025 Direct
PUMA BIOTECHNOLOGY, INC. Director Common Stock 400 $1.45K $3.63 Jun 13, 2025 By Child #1
PUMA BIOTECHNOLOGY, INC. Director Common Stock 150 $544 $3.63 Jun 13, 2025 By Child #2
Kura Oncology, Inc. President and CEO, Director Option to purchase common stock 625K Jan 2, 2025 Direct
Avidity Biosciences, Inc. Director Stock Option (Right to Buy) 0 Sep 5, 2025 Direct

Insider Reports Filed by Troy E. Wilson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KURA Kura Oncology, Inc. Nov 13, 2025 1 $0 4 Nov 14, 2025 President and CEO, Director
KURA Kura Oncology, Inc. Sep 27, 2025 2 -$327K 4 Sep 29, 2025 President and CEO, Director
KURA Kura Oncology, Inc. Sep 8, 2025 1 $410K 4 Sep 9, 2025 President & CEO, Director
RNA Avidity Biosciences, Inc. Sep 5, 2025 4 -$1.29M 4 Sep 9, 2025 Director
KURA Kura Oncology, Inc. Aug 12, 2025 2 $303K 4 Aug 14, 2025 President and CEO, Director
RNA Avidity Biosciences, Inc. Aug 6, 2025 10 -$3.92M 4 Aug 8, 2025 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 13, 2025 1 -$36.7K 4 Jun 17, 2025 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 11, 2025 1 $0 4 Jun 13, 2025 Director
RNA Avidity Biosciences, Inc. Jun 10, 2025 2 $0 4 Jun 12, 2025 Director
KURA Kura Oncology, Inc. Jan 2, 2025 1 $0 4 Jan 6, 2025 President and CEO, Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 18, 2024 1 $0 4 Jun 21, 2024 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 13, 2024 1 -$89.9K 4 Jun 17, 2024 Director
RNA Avidity Biosciences, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
KURA Kura Oncology, Inc. Jan 24, 2024 4 -$1.29M 4 Jan 26, 2024 President and CEO, Director
KURA Kura Oncology, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 President and CEO, Director
RNA Avidity Biosciences, Inc. Dec 12, 2023 4 $0 4 Dec 14, 2023 Director
KURA Kura Oncology, Inc. Dec 7, 2023 2 $0 4 Dec 11, 2023 President and CEO, Director
RNA Avidity Biosciences, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 13, 2023 2 -$93.3K 4 Jun 15, 2023 Director
KURA Kura Oncology, Inc. Jun 2, 2023 8 $0 4 Jun 2, 2023 President and CEO, Director
KURA Kura Oncology, Inc. Jul 14, 2022 8 $0 4 Feb 21, 2023 President and CEO, Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 16, 2022 1 -$72K 4 Jun 21, 2022 Director
RNA Avidity Biosciences, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
KURA Kura Oncology, Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 President and CEO, Director
RNA Avidity Biosciences, Inc. Jun 16, 2021 1 $0 4 Jun 16, 2021 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 10, 2021 1 -$292K 4 Jun 11, 2021 Director